ENTO

Entero Therapeutics Inc. - Common Stock (ENTO)

About Entero Therapeutics Inc. - Common Stock (ENTO)

Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

Details

Daily high
$0.39
Daily low
$0.36
Price at open
--
52 Week High
$3.16
52 Week Low
$0.18
Market cap
1.8M
Dividend yield
0.00%
Volume
3
Avg. volume
1.5M
P/E ratio
-.06

Entero Therapeutics Inc. - Common Stock News

Details

Daily high
$0.39
Daily low
$0.36
Price at open
--
52 Week High
$3.16
52 Week Low
$0.18
Market cap
1.8M
Dividend yield
0.00%
Volume
3
Avg. volume
1.5M
P/E ratio
-.06